The Osteosarcoma Institute

We fund research for osteosarcoma, a rare bone cancer affecting mainly children, adolescents, and young adults. Join us in #ConcentratingOnTheCure.

[The Osteosarcoma Institute @OSInstitute]

Thank you to everyone across the Mount Washington Valley in NH who supported Camden Bailey Cancer Foundation events benefiting Camdens' Quest 2 Cure Fund at OSI and osteosarcoma research for patients and families.
https://t.co/xrN74zEmy9
@conwaydailysun

[The Osteosarcoma Institute @OSInstitute]

Just starting your career? You can make a lasting impact with a planned gift. By naming OSI as a beneficiary on your retirement account or life insurance, your legacy can help fight osteosarcoma. Read more: https://t.co/fMWas61Bac

[The Osteosarcoma Institute @OSInstitute]

In honor of Willie Tichenor’s birthday, make a donation to OSI. 100% of proceeds go directly toward osteosarcoma research and advocacy, which is “What Willie Would Want.” Donate today: https://t.co/kDGf2OcE1D

[The Osteosarcoma Institute @OSInstitute]

Clinical trials move new osteosarcoma treatments from research to real life. From trial phases to benefits and risks, UT MD Anderson Cancer Center’s Dr. J. Andrew Livingston shares what families should know and the questions to ask. Read more: https://t.co/PajsIMi05F

[The Osteosarcoma Institute @OSInstitute]

May is #CancerResearchMonth, and OSI is proud to recognize and support the dedicated researchers who are working to improve osteosarcoma treatments. Read the latest on osteosarcoma research here: https://t.co/hUBbGpMcBr

[The Osteosarcoma Institute @OSInstitute]

May is #CancerResearchMonth, and OSI is proud to recognize and support the dedicated researchers who are working to improve osteosarcoma treatments. Read the latest on osteosarcoma research here: https://t.co/hUBbGpMcBr

[The Osteosarcoma Institute @OSInstitute]

The same healing process that repairs normal tissue also enables tumors to grow. Today, researchers are working to illuminate elements of cancer metastasis to find a cure for osteosarcoma. Read on: https://t.co/r7bEclNlRx

[The Osteosarcoma Institute @OSInstitute]

This year, Evan is celebrating 20 years of being cancer free after battling osteosarcoma as a teenager. Read his inspiring story and more: https://t.co/F1COYfVCYh

[MIB Agents Osteosarcoma Alliance @AgentsMIB]

Thursday, we were joined by Philippos Costa, MD on OsteoBites to dicuss, "Zanzalintinib in Osteosarcoma: Balancing Disease Control and Quality of Life".

Watch the full episode here: https://t.co/OBkSRRCnrL

#MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

[The Osteosarcoma Institute @OSInstitute]

Looking to make a difference? Start a Facebook fundraiser with OSI in minutes and raise money for osteosarcoma research and advocacy today. Learn more here: https://t.co/eqGQ7dpTX0

[AACR @AACR]

We are pleased to announce the 2026 recipients of the AACR Scientific Achievement Awards. We look forward to celebrating their impactful contributions to cancer research at the AACR Annual Meeting. https://t.co/5r0doflPr0 #AACR26

[The Osteosarcoma Institute @OSInstitute]

Congratulations to OSI-funded researcher Dr. David Lyden on receiving the @AACR Princess Takamatsu Memorial Lectureship. This recognition reflects the significance of his work in cancer metastasis and its potential to inform new approaches to treatment.
https://t.co/pgLfGaVccr

[The Osteosarcoma Institute @OSInstitute]

The Osteosarcoma Institute and the FDA brought together 370+ researchers, clinicians, and industry leaders to tackle barriers in osteosarcoma drug development. This collaboration is helping build smarter paths to new treatments. Read more: https://t.co/TaquSK9nSV

[The Osteosarcoma Institute @OSInstitute]

The OSI Strategic Advisory Board met last month to refresh OSI’s Scientific Strategic Plan and build consensus around new strategic initiatives to accelerate progress in osteosarcoma. Learn more about the SAB here: https://t.co/9v4KaMmP2f

[The Osteosarcoma Institute @OSInstitute]

Osteosarcoma is a rare disease which makes research and funding for drug development difficult. Learn about the four biggest challenges facing osteosarcoma drug development and how OSI is helping to break down these barriers: https://t.co/eqgvV8xouK

[The Osteosarcoma Institute @OSInstitute]

Through strategic funding, targeted research priorities, and high-impact partnerships, OSI is advancing osteosarcoma research in hopes of finding better treatments for patients and, ultimately, a cure. Learn more: https://t.co/YOvDhagpyB

[The Osteosarcoma Institute @OSInstitute]

Meet OSI’s incoming Executive Director, Alli Murdoff. Alli is expanding her long-standing relationship with OSI into a new, full time Executive Director position beginning April 1. Learn more about Alli and the OSI team: https://t.co/6aqomXYqUZ.

[The Osteosarcoma Institute @OSInstitute]

OSI is pleased to share a recently published perspective paper highlighting considerations for designing clinical trials for patients with relapsed and refractory osteosarcoma. Read the brief online here: https://t.co/9u3AfCSVuJ

[The Osteosarcoma Institute @OSInstitute]

@mat__nova @spike_0124 This is a beautiful tribute to your friend Scott. Thank you for sharing 💛💛💛

[Mat @mat__nova]

hello tezos folks, how do you deal with grief? @spike_0124
and i made an artwork collab about it

"i never forgot your empathy" is a tribute to scott's friend, matthew cook, who passed away from osteosarcoma

grief can take time to express and can take many forms like art 🙏